# Guangzhou Kangrui Biological Pharmaceutical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-kangrui-biological-pharmaceutical-technology-co

- Industry: Pharmaceuticals
- Headquarters: Guangzhou, China
- Latest round: Series A (Jan 28, 2022)
- Investors on record: 4

## About

Established in 2012 and based in Guangzhou, China, Guangzhou Kangrui Biological Pharmaceutical Technology Co.,Ltd. is a healthcare company focused on research, development and production of new drugs for ophthalmic diseases. The company has completed 4 rounds of funding as of 2022.

The company's main business is research in the fields of ophthalmology and genetics, including corneal limbal stem cell culture and transplantation technology, new drug research and development for ophthalmic diseases, research and development of ophthalmic disease-related genetic testing kits, etc., as well as related technology transfer, service and reagent sales.

## Funding rounds

- Series A, Jan 28, 2022 — Yuecai Zhongyin Private Equity, WinDigital Capital, Funway Capital
- Series A, Feb 1, 2015 — Yuexiu Industrial Investment Funds Management

## Investors

- Yuexiu Industrial Investment Funds Management (https://capitalatlas.ai/funds/yuexiu-industrial-investment-funds-management) — Series A
- Yuecai Zhongyin Private Equity (https://capitalatlas.ai/funds/yuecai-zhongyin-private-equity) — Series A
- WinDigital Capital (https://capitalatlas.ai/funds/windigital-capital) — Series A
- Funway Capital (https://capitalatlas.ai/funds/funway-capital) — Series A